JCIA
CSTL icon

Jackson Creek Investment Advisors’s Castle Biosciences CSTL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Sell
11,214
-21
-0.2% -$688 0.08% 288
2025
Q4 		$437K Buy
+11,235
New +$362K 0.13% 227
2025
Q2 		– Sell
-57,094
Closed -$1.14M – 328
2025
Q1 		$1.14M Buy
+57,094
New +$1.41M 0.36% 153

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jackson Creek Investment Advisors's CSTL Position: Q1 2026 in Review

Jackson Creek Investment Advisors reduced its Castle Biosciences (CSTL) stake by 0.19% in Q1 2026, selling an estimated $688 and leaving 11,214 shares worth $275K. The position accounts for 0.08% of the portfolio, ranked #288.

Jackson Creek Investment Advisors first reported a position in CSTL in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q1 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Jackson Creek Investment Advisors held 11,214 shares of Castle Biosciences worth $275K as of Q1 2026.
  • Jackson Creek Investment Advisors sold 21 Castle Biosciences shares in Q1 2026, an estimated $688.
  • Castle Biosciences made up 0.08% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #288 holding.
  • Jackson Creek Investment Advisors first reported a position in Castle Biosciences in Q1 2025 and has held it in 3 quarters since.
  • Jackson Creek Investment Advisors's Castle Biosciences position peaked at $1.14M in Q1 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.